The growing prevalence of cardiovascular disease is driving growth in demand for adult and pediatric

Poonamcmi22 Mar, 2022Health

The device prevents blood clotting and maintains hematocrit levels during cardiac surgery. The COVID-19 outbreak, which halted production and sales, limited the market's capacity to expand. Hemoconcentrators are used in heart surgery, cancer treatment, and the treatment of infectious diseases. Chronic diseases like COVID and CHF are unlikely to reduce in the next years, therefore market growth for these devices is predicted to remain strong. Adult and Pediatric Hemoconcentrators are one of the leading causes of death in the United States, according to the Organization for Economic Cooperation and Development. Cardiovascular diseases, albeit avoidable, are incurable and account for over one-third of all deaths. As a result, the market for Adult and Pediatric Hemoconcentrators is expected to grow substantially over the forecast period.